ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 753193 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 753193; 2) Community: the network communities that were significantly associated with the response to NSC 753193; 3) Molecule: the relationships between components within communities and NSC 753193; 4) MDR: the compounds that were significantly associated with the NSC 753193.

NSC Compound Enrichment Correlation
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.0329129886465389 0.10020389
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0329129886465389 0.63772113
NSC 749169 8H-thieno[2'3':4,5]pyrimido[2,1-a]phthalazin-8-one,5-[[3-(dimethylamino)propyl]amino]-9,10-dimethyl 0.0329129886465389 0.50729904
NSC 750050 Null 0.0329129886465389 0.46100405
NSC 133118 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) 0.0375780807984386 0.11302849
NSC 168516 Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- 0.0375780807984386 0.27372142
NSC 287069 Epicorazine A 0.0375780807984386 0.30203556
NSC 346098 Null 0.0375780807984386 0.16614802
NSC 350629 2-Propen-1-one, 2-[(dimethylamino)methy]-1-(4- .beta.-D-glucopyranosyloxyphenyl)-, tetraacetate ester 0.0375780807984386 0.37555742
NSC 354051 LISCUNDITRIN 0.0375780807984386 0.28258996
Total:100  Current:78    [First] [Prev] [Next] [Last]